#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Erythema Alveolar proteinosis Skin cancer Spinal muscular atrophy Thrombotic thrombocytopenic purpura Chronic graft versus host disease Vernal keratoconjunctivitis Multifocal motor neuropathy Hepatocellular carcinoma Breast angiosarcoma Bronchopulmonary aspergillosis Ovarian cancer stage IV Chronic lymphocytic leukaemia refractory Testicular leiomyosarcoma Acute myeloid leukaemia More trials…

    Learn about Rare Diseases

    Alveolar rhabdomyosarcoma Glomerulonephritis membranoproliferative – Life with Disease Primary biliary cholangitis – Trials in Disease Undifferentiated sarcoma – Treatment Mastocytosis – Life with Disease Haemophilia – Treatment Alternating hemiplegia of childhood – Diagnostics Encephalitis autoimmune – Treatment Ewing’s sarcoma metastatic Retinitis pigmentosa – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Meldonium Piperacillin Sodium Granisetron Potassium Iodide Reparixin Navtemadlin Ranitidine Hydrochloride COLESEVELAM HYDROCHLORIDE Pritelivir Dazodalibep Rhh646 Ixekizumab GSKVX000000030810 Ampicillin Sodium Potassium Canrenoate Grwd5769 Febuxostat Hemihydrate Gt005 Rosuvastatin Zinc Tavapadon More therapies…

    Learn about Your Condition

    Bronchitis Dementia Retinoblastoma Hyperlipidaemia Nasal sinus cancer Head and neck cancer Respiratory tract infection Hepatic adenoma Pouchitis Glioblastoma multiforme Haematological malignancy Endocarditis enterococcal Hepatic cirrhosis Graft infection Cerebral palsy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects of Ferric Carboxymaltose on Heart Health and Quality of Life in Patients with Recent Heart Attack and Iron Deficiency

    Recruiting

    3 1 1
    Investigated Diseases:
    • Myocardial infarction
    Investigated Drugs:
    • Ferric Carboxymaltose
    • Sodium Chloride
    Poland

  • Study of Pembrolizumab and V940 for Treating Non-Small Cell Lung Cancer in Patients with Resectable Stage II to IIIB (N2) Not Achieving Complete Response

    Recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Pemetrexed Disodium
    • Mrna-4157
    • Carboplatin
    Belgium Bulgaria Finland France Germany Greece +8

  • Comparison of Once Versus Twice Daily Prednisolone Administration on Blood Glucose Control in Patients with ANCA-Associated Vasculitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    Investigated Drugs:
    • Prednisolone
    Austria

  • Study on the Safety and Benefits of Recombinant Human Plasma Gelsolin for Patients with Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS)

    Recruiting

    2 1
    Investigated Diseases:
    • Acute respiratory distress syndrome
    Investigated Drugs:
    • Human Plasma Gelsolin, Recombinant
    Belgium Bulgaria Czechia France Germany Hungary +4

  • Study of nivolumab treatment for patients with nasopharyngeal cancer who did not respond to or worsened after platinum chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Keratinising squamous cell carcinoma of nasopharynx
    • Nasopharyngeal cancer
    • Nasopharyngeal cancer recurrent
    Investigated Drugs:
    • Nivolumab
    Poland

  • Study on Steroid Withdrawal in Systemic Lupus Erythematosus Patients Using Prednisone

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Prednisone
    Italy
Previous Page
1 … 422 423 424 425 426 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!